Digi.Bio is bridging the digital and biological world with AI and automation.
Digi.Bio develops a microfluidic platform designed to bridge the digital and biological world with AI and automation. It offers Automation of Synthetic Biology research using programmable microfluidics, EWOD, an innovative technology with miniaturization of experiments. The company was establishes in year 2017 in Amsterdam, The Netherlands.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 30, 2017 | Seed | — | 1 | — | — | Detail |